All Stories

  1. Protein post‐translational modifications and misfolding: New concepts in heart failure

    Article • PROTEOMICS - CLINICAL APPLICATIONS, August 2014, Wiley

    Dr Federica del Monte

  2. Gene expression and genetic variation in human atria

    Article • Heart Rhythm, February 2014, Elsevier

    Dr Federica del Monte

  3. Isolation, Culture, and Functional Characterization of Adult Mouse Cardiomyoctyes

    Article • Journal of Visualized Experiments, September 2013, MyJove Corporation

    Dr Federica del Monte

  4. Stanniocalcin1 is a key mediator of amyloidogenic light chain induced cardiotoxicity

    Article • Basic Research in Cardiology, August 2013, Springer Science + Business Media

    Dr Federica del Monte

  5. Atrial natriuretic peptide is negatively regulated by microRNA-425

    Article • Journal of Clinical Investigation, July 2013, American Society for Clinical Investigation

    Dr Federica del Monte

  6. Cardiac angiogenic imbalance leads to peripartum cardiomyopathy

    Article • Nature, May 2012, Springer Science + Business Media

    Dr Federica del Monte, Eliyahu V. Khankin, John Mitchell

  7. Presenilin Mediated Ca2+ Changes and Protein Quality Control in Heart Failure

    Article • Journal of Cardiac Failure, August 2011, Elsevier

    Dr Federica del Monte

  8. Regulation of Abro1/KIAA0157 during myocardial infarction and cell death reveals a novel cardioprotective mechanism for Lys63-specific deubiquitination

    Article • Journal of Molecular and Cellular Cardiology, April 2011, Elsevier

    Dr Federica del Monte

  9. Neonatal gene transfer of Serca2a delays onset of hypertrophic remodeling and improves function in familial hypertrophic cardiomyopathy

    Article • Journal of Molecular and Cellular Cardiology, December 2010, Elsevier

    Dr Federica del Monte

  10. Protein Aggregates and Novel Presenilin Gene Variants in Idiopathic Dilated Cardiomyopathy

    Article • Circulation, March 2010, Wolters Kluwer Health

    Dr Federica del Monte

  11. Compartmentalized expression of three novel sarco/endoplasmic reticulum Ca2+ATPase 3 isoforms including the switch to ER stress, SERCA3f, in non-failing and failing human heart

    Article • Cell Calcium, February 2009, Elsevier

    Dr Federica del Monte

  12. Rescue of Ca2+ overload-induced left ventriclur dysfunction by targeted ablation of phospholamban

    Article • AJP Heart and Circulatory Physiology, December 2008, American Physiological Society

    Dr Federica del Monte

  13. Progressive nature of chronic mitral regurgitation and the role of tissue Doppler-derived indexes

    Article • AJP Heart and Circulatory Physiology, March 2008, American Physiological Society

    Dr Federica del Monte

  14. Intracellular devastation in heart failure

    Article • Heart Failure Reviews, March 2008, Springer Science + Business Media

    Dr Federica del Monte

  15. Fingerprint Profile of Alcohol‐Associated Heart Failure in Human Hearts

    Article • Alcoholism Clinical and Experimental Research, March 2008, Wiley

    Dr Federica del Monte

  16. Mitral Regurgitation Augments Post-Myocardial Infarction Remodeling

    Article • Journal of the American College of Cardiology, January 2008, Elsevier

    Dr Federica del Monte

  17. Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair

    Article • Nature Reports Stem Cells, July 2007, Springer Science + Business Media

    Dr Federica del Monte

  18. Histidine-rich Ca-binding protein interacts with sarcoplasmic reticulum Ca-ATPase

    Article • AJP Heart and Circulatory Physiology, June 2007, American Physiological Society

    Dr Federica del Monte

  19. A novel Z-groove index characterizing myocardial surface structure and its modification in failing human heart

    Article • Journal of Molecular and Cellular Cardiology, June 2007, Elsevier

    Dr Federica del Monte

  20. Transcoronary gene transfer of SERCA2a increases coronary blood flow and decreases cardiomyocyte size in a Type 2 diabetic rat model

    Article • AJP Heart and Circulatory Physiology, October 2006, American Physiological Society

    Dr Federica del Monte

  21. Delayed erythropoietin therapy reduces post-MI cardiac remodeling only at a dose that mobilizes endothelial progenitor cells

    Article • AJP Heart and Circulatory Physiology, October 2006, American Physiological Society

    Dr Federica del Monte

  22. Histidine-rich Ca binding protein: a regulator of sarcoplasmic reticulum calcium sequestration and cardiac function

    Article • Journal of Molecular and Cellular Cardiology, May 2006, Elsevier

    Dr Federica del Monte

  23. Ca 2+ -ATPases in non-failing and failing heart: evidence for a novel cardiac sarco/endoplasmic reticulum Ca 2+ -ATPase 2 isoform (SERCA2c)

    Article • Biochemical Journal, April 2006, Portland Press Ltd.

    Dr Federica del Monte

  24. 1042. Tracking and Gene Expression Profile of Bone Marrow Mesenchymal Stem Cells Injected into Pig Myocardium by Magnetic Resonance Imaging and Laser-Capture Microdissection

    Article • Molecular Therapy, January 2006, Elsevier

    Dr Federica del Monte

  25. Rescue of Ca2+ Overload-induced Left Ventricle Dysfunction by Targeted Ablation of Phospholamban

    Article • Journal of Cardiac Failure, December 2005, Elsevier

    Dr Federica del Monte

  26. PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury

    Article • Journal of Clinical Investigation, August 2005, American Society for Clinical Investigation

    Dr Federica del Monte

  27. Protein Unfolding in Cardiomyopathies

    Article • Heart Failure Clinics, July 2005, Elsevier

    Dr Federica del Monte

  28. Pathogenesis of Heart Failure

    Article • Heart Failure Clinics, July 2005, Elsevier

    Dr Federica del Monte

  29. Transgenic Models of Heart Failure: Elucidation of the Molecular Mechanisms of Heart Disease

    Article • Heart Failure Clinics, July 2005, Elsevier

    Dr Federica del Monte

  30. Genetic maneuvers to ameliorate ventricular function in heart failure: therapeutic potential and future implications

    Article • Expert Review of Cardiovascular Therapy, January 2005, Taylor & Francis

    Dr Federica del Monte

  31. Cardiovascular Gene and Cell Therapy

    Article • January 2005, Springer Science + Business Media

    Dr Federica del Monte

  32. Transcriptional changes following restoration of SERCA2a levels in failing rat hearts

    Article • The FASEB Journal, July 2004, Wiley

    Dr Federica del Monte

  33. Cardiac-Specific Gene Expression Facilitated by an Enhanced Myosin Light Chain Promoter

    Article • Molecular Imaging, April 2004, SAGE Publications

    Dr Federica del Monte

  34. Gene transfer in cardiac myocytes

    Article • Surgical Clinics of North America, February 2004, Elsevier

    Dr Federica del Monte

  35. The protein phosphatase 1 inhibitor-1: a potent “molecular inotrope” in cardiac function

    Article • Journal of Cardiac Failure, October 2003, Elsevier

    Dr Federica del Monte

  36. CARDIAC SPECIFIC PROMOTER FOR MYOCARDIAL GENE TRANSFER

    Article • Anesthesiology, September 2003, Wolters Kluwer Health

    Dr Federica del Monte

  37. Gene therapy for the treatment of heart failure—calcium signaling

    Article • Seminars in Thoracic and Cardiovascular Surgery, July 2003, Elsevier

    Dr Federica del Monte

  38. Targeting calcium cycling proteins in heart failure through gene transfer

    Article • The Journal of Physiology, January 2003, Wiley

    Dr Federica del Monte

  39. Functional Near-Infrared Imaging for Cardiac Surgery and Targeted Gene Therapy

    Article • Molecular Imaging, October 2002, SAGE Publications

    Dr Federica del Monte

  40. Targeting Ca2+ cycling proteins and the action potential in heart failure by gene transfer

    Article • Basic Research in Cardiology, May 2002, Springer Science + Business Media

    Dr Federica del Monte

  41. Targeting Phospholamban by Gene Transfer in Human Heart Failure

    Article • Circulation, February 2002, Wolters Kluwer Health

    Dr Federica del Monte

  42. Improvement in Survival and Cardiac Metabolism After Gene Transfer of Sarcoplasmic Reticulum Ca 2+ -ATPase in a Rat Model of Heart Failure

    Article • Circulation, September 2001, Wolters Kluwer Health

    Dr Federica del Monte

  43. Overwhelming Evidence of the Beneficial Effects of SERCA Gene Transfer in Heart Failure

    Article • Circulation Research, June 2001, Wolters Kluwer Health

    Dr Federica del Monte

  44. Differential Activation of Signal Transduction Pathways in Human Hearts With Hypertrophy Versus Advanced Heart Failure

    Article • Circulation, February 2001, Wolters Kluwer Health

    Dr Federica del Monte

  45. Prospects for Gene Therapy for Heart Failure

    Article • Circulation Research, March 2000, Wolters Kluwer Health

    Dr Federica del Monte

  46. Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure

    Article • Proceedings of the National Academy of Sciences, January 2000, Proceedings of the National Academy of Sciences

    Dr Federica del Monte

  47. Restoration of contractile function in isolated failing human ventricular cardiac myocytes by gene transfer of SERCA2a

    Article • Journal of Cardiac Failure, September 1999, Elsevier

    Dr Federica del Monte

  48. Regulation of cardiac hypertrophy in vivo by the stress-activated protein kinases/c-Jun NH2-terminal kinases

    Article • Journal of Clinical Investigation, August 1999, American Society for Clinical Investigation

    Dr Federica del Monte

  49. Protection of Human Myocardium In Vitro by KATP Activation with Low Concentrations of Bimakalim

    Article • Journal of Cardiovascular Pharmacology, July 1999, Wolters Kluwer Health

    Dr Federica del Monte

  50. Cyclic AMP levels in ventricular myocytes from noradrenaline-treated guinea-pigs

    Article • European Journal of Pharmacology, August 1996, Elsevier

    Dr Federica del Monte

  51. Cell geometry and contractile abnormalities of myocytes from failing human left ventricle

    Article • Cardiovascular Research, August 1995, European Society of Cardiology

    Dr Federica del Monte

  52. Myocardial Cell Abnormalities in Heart Failure: Experience from Studies on Single Myocytes

    Article • January 1995, Springer Science + Business Media

    Dr Federica del Monte

  53. Coexistence of functioning beta 1- and beta 2-adrenoceptors in single myocytes from human ventricle.

    Article • Circulation, September 1993, Wolters Kluwer Health

    Dr Federica del Monte

  54. Reduced contractile responses to forskolin and a cyclic AMP analogue in myocytes from failing human ventricle

    Article • European Journal of Pharmacology, November 1992, Elsevier

    Dr Federica del Monte

  55. Contraction of cardiac myocytes from noradrenaline-treated rats in response to isoprenaline, forskolin and dibutyryl cAMP

    Article • European Journal of Pharmacology, November 1990, Elsevier

    Dr Federica del Monte

  56. Antisense Strategies for Treatment of Heart Failure

    Article • Springer Science + Business Media

    Dr Federica del Monte

  57. Efficient Viral Gene Transfer to Rodent Hearts In Vivo

    Article • Springer Science + Business Media

    Dr Federica del Monte

  58. Heart Failure

    Article • Springer Science + Business Media

    Dr Federica del Monte